Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neuro Endocrinol Lett ; 28 Suppl 3: 23-4, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18030271

ABSTRACT

Within last 17 years we went through all charts of bacterial meningitis within our nationwide survey and among 372 cases we found 62 cases of MM, in 12 cases with meningococcal disease (with shock, petechial effusions or disseminated intravascular coagulation or digital gangrenes). MM was usually observed in young adults without any of investigated risk factors like neoplasia, ENT (ear, nose, throat) focuses, elderly age, sepsis, diabetes, alcoholism, trauma, neonatal VLBW etc. Trauma, diabetes mellitus, alcohol abuse and chronic sinusitis/otitis were significantly less frequently found as a risk factor for MM. Mortality was very low, only 4.8% and was lower than overall mortality in CBM (12.4%, NS). Also the proportion of neurologic sequellae (9.7%) and initial treatment failure (8.1%) were comparable or even lower. This positive outcome results are probably because all N. meningitis strains were susceptible to penicillin, chloramphenicol, cefotaxim, cotrimoxazol or ciprofloxacin. Other reason for low mortality was that most cases received oral antibiotic immediately, even before admission (50 of 62). 95.2% of cases survived, 90.3% without any transient neurological residual symptoms.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Meningitis, Meningococcal/epidemiology , Meningococcal Infections/epidemiology , Tropical Medicine , Cephalosporins/therapeutic use , Community-Acquired Infections/drug therapy , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Community-Acquired Infections/mortality , Humans , Meningitis, Meningococcal/drug therapy , Meningitis, Meningococcal/mortality , Meningococcal Infections/drug therapy , Meningococcal Infections/mortality , Outcome Assessment, Health Care , Penicillins/therapeutic use , Retrospective Studies , Risk Factors
2.
Neuro Endocrinol Lett ; 28 Suppl 3: 28-9, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18030274

ABSTRACT

Community acquired bacterial (CBM) meningitis in diabetic patients was analyzed for risk factors and outcome in a cohort of 201 cases of meningitis within last 17 years: 15 patients with diabetes mellitus and meningitis were identified and compared for etiology and mortality as well as for neurologic sequellae with all CBM cases.


Subject(s)
Diabetes Complications/microbiology , Diabetes Mellitus/immunology , Meningitis, Bacterial/etiology , Anti-Bacterial Agents/therapeutic use , Cefotaxime/therapeutic use , Cohort Studies , Community-Acquired Infections/microbiology , Community-Acquired Infections/mortality , Community-Acquired Infections/therapy , Diabetes Complications/immunology , Diabetes Complications/therapy , Humans , Meningitis, Bacterial/mortality , Meningitis, Bacterial/therapy , Outcome Assessment, Health Care , Risk Factors , Vancomycin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...